![David N. Jonas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David N. Jonas
Fondateur chez
JVC Investment Partners LLC
Profil
David N.
Jonas is the founder.
Mr. Jonas was the founder of PharMEDium Healthcare LLC, serving as Chairman in 2014.
Mr. Jonas is the founder of JVC Investment Partners LLC, serving as Partner since 2000.
Mr. Jonas is also the founder of Renal Therapy Services Worldwide, Inc. Mr. Jonas is currently a Director at PharMEDium Healthcare Holdings, Inc. since 2014 and a Director at Reliefband Technologies LLC.
Former positions include Director at Chicago Medical School and Vice President-Global Corporate Development at Baxter International, Inc. Education includes undergraduate and MBA degrees from Roosevelt University.
Postes actifs de David N. Jonas
| Sociétés | Poste | Début |
|---|---|---|
PharMEDium Healthcare Holdings, Inc.
 PharMEDium Healthcare Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures and sells outsourced compounded sterile preparations apparatus | Directeur/Membre du Conseil | 01/01/2014 |
JVC Investment Partners LLC
 JVC Investment Partners LLC Investment ManagersFinance JVC Investment Partners invests in middle market companies located in the United States. The firm focuses on companies operating in the healthcare sector. It provides financing for early and buyout capital requirements. | Fondateur | 01/01/2000 |
Reliefband Technologies LLC
 Reliefband Technologies LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures and sells wearable band through online store which controls nausea and vomiting | Directeur/Membre du Conseil | - |
Anciens postes connus de David N. Jonas
| Sociétés | Poste | Fin |
|---|---|---|
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Renal Therapy Services Worldwide, Inc. | Fondateur | - |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | - |
PharMEDium Healthcare LLC
 PharMEDium Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides hospital pharmacy-outsourced sterile compounding services | Directeur Général | 12/02/2014 |
Formation de David N. Jonas
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
20
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
PharMEDium Healthcare Holdings, Inc.
PharMEDium Healthcare Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures and sells outsourced compounded sterile preparations apparatus | Health Technology |
PharMEDium Healthcare LLC
PharMEDium Healthcare LLC Pharmaceuticals: MajorHealth Technology Provides hospital pharmacy-outsourced sterile compounding services | Health Technology |
Roosevelt University
 Roosevelt University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Renal Therapy Services Worldwide, Inc. | |
Chicago Medical School
Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reliefband Technologies LLC
Reliefband Technologies LLC Electronic Equipment/InstrumentsElectronic Technology Manufactures and sells wearable band through online store which controls nausea and vomiting | Electronic Technology |
JVC Investment Partners LLC
JVC Investment Partners LLC Investment ManagersFinance JVC Investment Partners invests in middle market companies located in the United States. The firm focuses on companies operating in the healthcare sector. It provides financing for early and buyout capital requirements. | Finance |
